For the Fifth Year, Benchmark Research / VaxCorps Awarded “Best Clinical Trial Site Network” at ViE Awards
AUSTIN, Texas (PRWEB) June 08, 2018 -- BENCHMARK RESEARCH, founding member of VaxCorps, along with members PMG Research and Research Centers of America, were honored with being chosen “Best Clinical Trial Site Network” at the annual Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress in Washington, DC.
Benchmark Research is proud to be the recipient of this award for the fifth time, achieving this honor more than any other company, and in any other category. The ViE Awards were created to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry.
“We congratulate our co-winners PMG & RCA. We are also deeply grateful to have been chosen in the top two sites/networks for eight consecutive years, and are proud that no other company has achieved these accolades in any other category. Finally, and most importantly, we are blessed by all the Benchmark Family employees, who ultimately are responsible for this prestigious award" said Mark Lacy, CEO of Benchmark Research.
About Benchmark Research, Inc.
Benchmark Research is a geographically diverse, fully-integrated network of multi-therapeutic research centers across three states. Benchmark Research owns Benchmark Urgent & Family Care Centers as part of their portfolio with several more to follow. Benchmark continues to both expand and innovate in their quest to maintain their standing as the leading site network in the clinical research industry.
Van Johnson, Benchmark Research, http://www.BenchmarkResearch.net, +1 469-854-0294, [email protected]
Share this article